You are here: Industry Insights > Vaccine

News List

Hope for Africa in fight against RSV and new vaccine shows promise SHEM OIRERE
September 01, 2020
Africa’s hope of further reducing the neonatal deaths estimated at 28 per 1,000 live births, has received a major boost...
Developments and Critical Issues of COVID-19 Treatment/Vaccine R&D in China PharmaSources.com
September 21, 2020
It has been over half a year since the pandemic first outbroke in Wuhan of China. This article is to review and update what we know about treatments and vaccines development, and critical issues in the fight against the pandemic.
The CDE Issuing Documents to Promote the Marketing of COVID-19 Vaccines & An Overview of the Clinical Data of the Seven COVID-19 Vaccines in the World PharmaSources/Xiaoyaowan
August 24, 2020
The CDE issued five documents including the Technical Guidelines for the Research and Development of Prophylactic Vaccines against COVID-19 (Trial) on Aug. 14.
Will the Bottles be Enough with the Marketing of COVID-19 Vaccine? PharmaSources/Laoxue
June 05, 2020
The National Medical Products Administration of China issued an announcement on the chemical drug injection consistency evaluation on May 14.
AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside PR Newswire
February 24, 2025
AIM Vaccine Co., Ltd. fully deploys DeepSeek large model, promoting its application in vaccine R & D, clinical, production, etc., with growth potential.
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development B3C newswire
November 06, 2023
ProBioGen and GeoVax Labs, announce the signing of a landmark commercial license agreement for ProBioGen's groundbreaking AGE1.
Malaysian Genomics Pivots to Biopharmaceuticals for Growth PharmaSources
March 07, 2023
Group reports lower revenue for 2Q on switch to immunotherapy and cell therapies from vaccines
New government plan to speed up elimination of cervical cancer www.gov.cn
February 08, 2023
The central government has outlined a long-term plan to accelerate the elimination of cervical cancer by 2030 via an initiative aimed at boosting vaccination rates among girls.
Celonic to Become a Long-Term Partner of the Federal Republic of Germany for Vaccine Supply b3cnewswire.com
March 28, 2022
The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics...
Novavax files for Conditional Marketing Authorisation of COVID-19 vaccine in Switzerland ExpressPharma
February 15, 2022
The submission for the regulatory evaluation of the vaccine includes data from two phase-III clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page